Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung

7680627320014 CH-62732 Injektionslösung
Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung
Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung
Xofigo 1100 kBq/ml Ra-223-Dichlorid, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/11/2021
Summary of Product Characteristics
Français
09/11/2021
Summary of Product Characteristics
Italien
09/11/2021

Detailed composition

Substance Quantity Type Category
(N/A)
6600.0 KBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
26.4 MG Substance HBESI

Reimbursement information

Public price
CHF 5276.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2014

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
62732
Drug name
Xofigo, Injektionslösung
Galenic form
LSPA
ATC Code
V10XX03
Authorization status
Z
Dispensing category
A
First authorization
29/08/2014
Authorization expiration date
31/12/9999
IT Number
17.02.
Domain
Human medicine
Field of application
Symptomatische Knochenmetastasen bei kastrationsresistentem Prostatakarzinom

Package details

Description (FR)
XOFIGO sol inj 6600 kBq/6ml vial 6 ml
Description (DE)
XOFIGO Inj Lös 6600 kBq/6ml Vial 6 ml
Market launch
29/08/2014
Narcotic (BTM)
No